Lung Cancer
Volume 67, Issue 2 , Pages 151-159 , February 2010

Identification of genes associated with non-small-cell lung cancer promotion and progression

  • Jasna Bankovic

      Affiliations

    • University of Belgrade, Institute for Biological Research, Department of Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
    • ,
  • Jelena Stojsic

      Affiliations

    • Institute for Lung Diseases and Tuberculosis, Clinical Centre of Serbia, Visegradska 26, 11000 Belgrade, Serbia
    • ,
  • Dragana Jovanovic

      Affiliations

    • Institute for Lung Diseases and Tuberculosis, Clinical Centre of Serbia, Visegradska 26, 11000 Belgrade, Serbia
    • ,
  • Tijana Andjelkovic

      Affiliations

    • University of Belgrade, Institute for Biological Research, Department of Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
    • ,
  • Vedrana Milinkovic

      Affiliations

    • University of Belgrade, Institute for Biological Research, Department of Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
    • ,
  • Sabera Ruzdijic

      Affiliations

    • University of Belgrade, Institute for Biological Research, Department of Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
    • ,
  • Nikola Tanic

      Affiliations

    • University of Belgrade, Institute for Biological Research, Department of Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia
    • Corresponding Author InformationCorresponding author at: Institute for Biological Research, Department of Neurobiology, Laboratory for Molecular Neurobiology, Bulevar Despota Stefana 142, 11060 Belgrade, Serbia. Tel.: +381 11 2078 410; fax: +381 11 2761 433.

Received 30 December 2008 ,Revised 15 April 2009 ,Accepted 19 April 2009.

References 

  1. Lantuejoul S, Brambilla E. Prognostic biomarkers in non-small-cell lung carcinoma. Curr Diag Pathol. 2006;12:418–428
  2. Lam WK, Watkins DN. Lung cancer: future directions. Respirology. 2007;12:471–477
  3. Breuer RH, Postmus PE, Smit EF. Molecular pathology of non-small-cell lung cancer. Respiration. 2005;72:313–330
  4. Welsh J, McClelland M. Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acid Res. 1990;18:7213–7218
  5. Markovic J, Stojsic J, Zunic S, Ruzdijic S, Tanic N. Genomic instability in patients with non-small cell lung cancer assessed by the arbitrarily primed polymerase chain reaction. Cancer Invest. 2008;26:262–268
  6. Achille A, Biasi MO, Zamboni G, Bogina G, Magalini AR, Pederzoli P, et al. Scarpa A. Chromosome 7q allelic losses in pancreatic carcinoma. Cancer Res. 1996;56:3808–3813
  7. Luo L, Li B, Pretlow TP. DNA alterations in human aberrant crypt foci and colon cancers by random primed polymerase chain reaction. Cancer Res. 2003;63:6166–6169
  8. De Juan C, Iniesta P, Cruces J, Sanchez A, Massa MJ, Gonzalez-Quevedo R, et al. DNA amplification on chromosome 6p12 in non small cell lung cancer detected by arbitrarily primed polymerase chain reaction. Int J Cancer. 1999;84:344–439
  9. Ong TM, Song B, Qian HW, Wu ZL, Whong WZ. Detection of genomic instability in lung cancer tissues by random amplified polymorphic DNA analysis. Carcinogenesis. 1998;19:233–235
  10. Singh KP, Roy D. Identification of novel breast tumor-specific mutation(s) in the q11.2 region of chromosome 17 by RAPD/AP-PCR fingerprinting. Gene. 2001;269:33–43
  11. Zhang SH, Cong WM, Xian ZH, Dong H, Wu MC. Genomic instability in hepatocellular carcinoma revealed by using the random amplified polymorphic DNA method. J Cancer Res Clin Oncol. 2004;130:757–761
  12. Chariyalertsak S, Khuhaprema T, Bhudisawasdi BS, Wongkham S, Petmitr S. Novel DNA amplification on chromosome 2p25.3 and 7q11. 23 in cholangiocarcinoma identified by arbitrarily primed polymerase chain reaction. J Cancer Res Clin Oncol. 2005;131:821–828
  13. In:  Travis WD,  Brambilla E,  Müller-Hermelink HK,  Harris CC editor. WHO classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC, Press; 2004;
  14. Sambrook J, Fritch EF, Maniatis T. Molecular cloning: a laboratory manual. second ed.. Cold Spring Harbor: Laboratory Press; 1989;
  15. Cobb B. Optimization of RAPD fingerprinting. In:  Micheli MR,  Bova R editor. Fingerprinting Methods Based on Arbitrarily Primed PCR. Berlin, Heidelberg: Springer Lab Manual, Springer Verlag; 1997;p. 93–103
  16. McClelland M, Welsh J. DNA fingerprinting by arbitrarily primed PCR. PCR Methods. 1994;4:S59–S65
  17. Antonarakis SE, Krawczak M, Cooper DN. The nature and mechanisms of human gene mutation. In:  Vogelstein B,  Kinzler KW editor. The Genetic Basis of Human Cancer. New York: McGraw-Hill; 2002;p. 7–42
  18. Berditchevski F, Odintsova E. Tetraspanins as regulators of protein trafficking. Traffic. 2007;8:89–96
  19. Lazo PA. Functional implications of tetraspanin proteins in cancer biology. Cancer Sci. 2007;98:1666–1677
  20. Higashiyama M, Taki T, Ieki Y, Adachi M, Huang CL, Koh T, et al. Reduced motility related protein-1 (MRP-1/CD9) gene expression as a factor of poor prognosis in non-small cell lung cancer. Cancer Res. 1995;55:6040–6044
  21. Funakoshi T, Tachibana I, Hoshida Y, Kimura H, Takeda Y, Kijima T, et al. Expression of tetraspanins in human lung cancer cells: frequent downregulation of CD9 and its contribution to cell motility in small cell lung cancer. Oncogene. 2003;22:674–687
  22. Uldry M, Ibberson M, Horisberger JD, Chatton JY, Riederer BM, Thorens B. Identification of a mammalian H(+)-myo-inositol symporter expressed predominantly in the brain. EMBO J. 2001;20:4467–4477
  23. Brognard J, Clark AS, Ni Y, Dennis PA. Akt/protein kinase B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Res. 2001;61:3986–3997
  24. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol. 2002;169:1102–1109
  25. Pallasch CP, Struss AK, Munnia A, König J, Steudel WI, Fischer U, et al. Autoantibodies against GLEA2 and PHF3 in glioblastoma: tumor-associated autoantibodies correlated with prolonged survival. Int J Cancer. 2005;117:456–459
  26. Guengerich FP. Metabolism of chemical carcinogens. Carcinogenesis (Lond). 2000;21:345–351
  27. Murray GI. The role of cytochrome P450 in tumour development and progression and its potential in therapy. J Pathol. 2000;192:419–426
  28. Quintieri L, Rosato A, Napoli E, Sola F, Geroni C, Floreani M, et al. In vivo antitumor activity and host toxicity of methoxymorpholinyl doxorubicin: role of cytochrome P450 3A. Cancer Res. 2000;60:3232–3238
  29. Lanier LL. On guard—activating NK cell receptors. Nat Immunol. 2001;2:23–27
  30. Carrega P, Morandi B, Costa R, Frumento G, Forte G, Altavilla G, et al. Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer. 2008;112:863–875
  31. Wu BX, Chen Y, Chen Y, Fan J, Rohrer B, Crouch RK, et al. Cloning and characterization of a novel all-trans retinol short-chain dehydrogenase/reductase from the RPE. Invest Ophthalmol Vis Sci. 2002;43:3365–3372
  32. Picozzi P, Marozzi A, Fornasari D, Benfante R, Barisani D, Meneveri R, et al. Genomic organization and transcription of the human retinol dehydrogenase 10 (RDH10) gene. FEBS Lett. 2003;554:59–66
  33. Epping MT, Wang L, Edel MJ, Carlée L, Hernandez M, Bernards R. The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell. 2005;122:835–847
  34. Lokshin A, Zhang H, Mayotte J, Lokshin M, Levitt ML. Early effects of retinoic acid on proliferation, differentiation and apoptosis in non-small cell lung cancer cell lines. Anticancer Res. 1999;19:5251–5254
  35. Chalmers IJ, Höfler H, Atkinson MJ. Mapping of a cadherin gene cluster to a region of chromosome 5 subject to frequent allelic loss in carcinoma. Genomics. 1999;57:160–163
  36. Ikeda H, Lethé B, Lehmann F, van Baren N, Baurain JF, de Smet C, et al. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 1997;6:199–208
  37. Sardet C, Vidal M, Cobrinik D, Geng Y, Onufryk C, Chen A, et al. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. PNAS. 1995;92:2403–2407
  38. Sagara J, Higuchi T, Hattori Y, Moriya M, Sarvotham H, Shima H, et al. Scapinin, a putative protein phosphatase-1 regulatory subunit associated with the nuclear nonchromatin structure. J Biol Chem. 2003;278:45611–45619
  39. Flores-Delgado G, Liu CW, Sposto R, Berndt N. A limited screen for protein interactions reveals new roles for protein phosphatase 1 in cell cycle control and apoptosis. J Proteome Res. 2007;6:1165–1175

PII: S0169-5002(09)00248-7

doi: 10.1016/j.lungcan.2009.04.010

Lung Cancer
Volume 67, Issue 2 , Pages 151-159 , February 2010

Article Tools

* Image Usage & Resolution